These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 1378879)
21. Antigenic variation of human and bovine parainfluenza virus type 3 strains. Klippmark E; Rydbeck R; Shibuta H; Norrby E J Gen Virol; 1990 Jul; 71 ( Pt 7)():1577-80. PubMed ID: 1695673 [TBL] [Abstract][Full Text] [Related]
22. The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. Sheshberadaran H; Norrby E; McCullough KC; Carpenter WC; Orvell C J Gen Virol; 1986 Jul; 67 ( Pt 7)():1381-92. PubMed ID: 2425047 [TBL] [Abstract][Full Text] [Related]
23. Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages. Hetherington SV; Watson AS; Scroggs RA; Portner A J Infect Dis; 1994 Feb; 169(2):248-52. PubMed ID: 7508966 [TBL] [Abstract][Full Text] [Related]
24. Immunological response of monkeys infected intranasally with human parainfluenza virus type 4. Komada H; Tsurudome M; Bando H; Nishio M; Ueda M; Tsumura H; Ito Y J Gen Virol; 1989 Dec; 70 ( Pt 12)():3487-92. PubMed ID: 2481714 [TBL] [Abstract][Full Text] [Related]
25. Two distinct human parainfluenza virus type 1 genotypes detected during the 1991 Milwaukee epidemic. Henrickson KJ; Savatski LL J Clin Microbiol; 1996 Mar; 34(3):695-700. PubMed ID: 8904440 [TBL] [Abstract][Full Text] [Related]
26. Protective effects of monoclonal antibodies against parainfluenza virus type 3-induced brain infection in hamsters. Rydbeck R; Löve A; Norrby E J Gen Virol; 1988 May; 69 ( Pt 5)():1019-24. PubMed ID: 2836547 [TBL] [Abstract][Full Text] [Related]
27. Characterization of Bangor virus proteins by using monoclonal antibodies. Mao X; Kusagawa S; Tsurudome M; Komada H; Kawano M; Nishio M; Ito Y Avian Dis; 1996; 40(1):150-7. PubMed ID: 8713029 [TBL] [Abstract][Full Text] [Related]
28. Sequence analyses of human parainfluenza virus type 4A and type 4B fusion proteins. Komada H; Bando H; Ito M; Ohta H; Kawano M; Nishio M; Tsurudome M; Watanabe N; Ikemura N; Kusagawa S J Gen Virol; 1995 Dec; 76 ( Pt 12)():3205-10. PubMed ID: 8847531 [TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies against human paramyxovirus type 3 and against SV5 virus: preparation and preliminary characterization. Goswami KK; Russell WC J Gen Virol; 1983 Aug; 64 (Pt 8)():1663-72. PubMed ID: 6192203 [TBL] [Abstract][Full Text] [Related]
30. Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants. Terrier O; Cartet G; Ferraris O; Morfin F; Thouvenot D; Hong SS; Lina B J Clin Virol; 2008 Sep; 43(1):86-92. PubMed ID: 18579437 [TBL] [Abstract][Full Text] [Related]
31. Distinct hemagglutinin and neuraminidase epitopes involved in antigenic variation of recent human parainfluenza virus type 2 isolates. Ray R; Duncan J; Quinn R; Matsuoka Y Virus Res; 1992 Jun; 24(1):107-13. PubMed ID: 1378237 [TBL] [Abstract][Full Text] [Related]
32. Isolation of monoclonal antibodies directed against the V protein of human parainfluenza virus type 2 and localization of the V protein in virus-infected cells. Nishio M; Tsurudome M; Ito M; Kawano M; Kusagawa S; Komada H; Ito Y Med Microbiol Immunol; 1999 Nov; 188(2):79-82. PubMed ID: 10753059 [TBL] [Abstract][Full Text] [Related]
33. Antigenic variation among Sendai virus strains detected by monoclonal antibodies. Yamaguchi R; Iwai H; Ueda K Microbiol Immunol; 1989; 33(2):133-9. PubMed ID: 2541319 [TBL] [Abstract][Full Text] [Related]
34. Characterization of major structural proteins of measles virus with monoclonal antibodies. Sato TA; Fukuda A; Sugiura A J Gen Virol; 1985 Jul; 66 ( Pt 7)():1397-409. PubMed ID: 2410551 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies to three structural proteins of Newcastle disease virus: biological characterization with particular reference to the conformational change of envelope glycoproteins associated with proteolytic cleavage. Umino Y; Kohama T; Sato TA; Sugiura A; Klenk HD; Rott R J Gen Virol; 1990 May; 71 ( Pt 5)():1189-97. PubMed ID: 1693166 [TBL] [Abstract][Full Text] [Related]
36. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase. Chibanga VP; Dirr L; Guillon P; El-Deeb IM; Bailly B; Thomson RJ; von Itzstein M Antiviral Res; 2019 Jul; 167():89-97. PubMed ID: 30951732 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to infectious pancreatic necrosis virus: analysis of viral epitopes and comparison of different isolates. Caswell-Reno P; Reno PW; Nicholson BL J Gen Virol; 1986 Oct; 67 ( Pt 10)():2193-205. PubMed ID: 2428927 [TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody. Tsurudome M; Yamada A; Hishiyama M; Ito Y J Gen Virol; 1986 Oct; 67 ( Pt 10)():2259-65. PubMed ID: 3760826 [TBL] [Abstract][Full Text] [Related]
39. Immunological interrelationships among human and non-human paramyxoviruses revealed by immunoprecipitation. Ito Y; Tsurudome M; Hishiyama M; Yamada A J Gen Virol; 1987 May; 68 ( Pt 5)():1289-97. PubMed ID: 3572366 [TBL] [Abstract][Full Text] [Related]
40. Protective effect of monoclonal antibodies to Newcastle disease virus in passive immunization. Umino Y; Kohama T; Sato TA; Sugiura A J Gen Virol; 1990 May; 71 ( Pt 5)():1199-203. PubMed ID: 2345369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]